<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is the most rapidly increasing <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in western countries </plain></SENT>
<SENT sid="1" pm="."><plain>High-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (HGD) arising from <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (BE) is the most important risk factor for its development, and when it is present the reported incidence is up to 10% per patient-year </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0009308'>Adenocarcinoma</z:mp> in the setting of BE develops through a well known histological sequence, from non-dysplastic Barrett's to low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and then HGD and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Endoscopic surveillance programs have been established to detect the presence of <z:hpo ids='HP_0002664'>neoplasia</z:hpo> at a potentially curative stage </plain></SENT>
<SENT sid="4" pm="."><plain>Newly developed endoscopic treatments have dramatically changed the therapeutic approach of BE </plain></SENT>
<SENT sid="5" pm="."><plain>When <z:hpo ids='HP_0002664'>neoplasia</z:hpo> is confined to the mucosal layer the risk for developing lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is negligible and can be successfully eradicated by an endoscopic approach, offering a curative intention treatment with minimal invasiveness </plain></SENT>
<SENT sid="6" pm="."><plain>Endoscopic therapies include resection techniques, also known as tissue-acquiring modalities, and ablation therapies or non-tissue acquiring modalities </plain></SENT>
<SENT sid="7" pm="."><plain>The aim of endoscopic treatment is to eradicate the whole Barrett's segment, since the risk of developing synchronous and metachronous lesions due to the persistence of molecular aberrations in the residual epithelium is well established </plain></SENT>
</text></document>